Master Regulator Analysis of the SARS-CoV-2/Human Interactome

The recent epidemic outbreak of a novel human coronavirus called SARS-CoV-2 causing the respiratory tract disease COVID-19 has reached worldwide resonance and a global effort is being undertaken to characterize the molecular features and evolutionary origins of this virus. In this paper, we set out...

Full description

Bibliographic Details
Main Authors: Pietro H. Guzzi, Daniele Mercatelli, Carmine Ceraolo, Federico M. Giorgi
Format: Article
Language:English
Published: MDPI AG 2020-04-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/9/4/982
id doaj-f4ed5a7024ea4406b2b63668647e6636
record_format Article
spelling doaj-f4ed5a7024ea4406b2b63668647e66362020-11-25T01:45:56ZengMDPI AGJournal of Clinical Medicine2077-03832020-04-01998298210.3390/jcm9040982Master Regulator Analysis of the SARS-CoV-2/Human InteractomePietro H. Guzzi0Daniele Mercatelli1Carmine Ceraolo2Federico M. Giorgi3Department of Surgical and Medical Science, University of Catanzaro, 88100 Catanzaro, ItalyDepartment of Pharmacy and Biotechnology, University of Bologna, 40126 Bologna, ItalyDepartment of Pharmacy and Biotechnology, University of Bologna, 40126 Bologna, ItalyDepartment of Pharmacy and Biotechnology, University of Bologna, 40126 Bologna, ItalyThe recent epidemic outbreak of a novel human coronavirus called SARS-CoV-2 causing the respiratory tract disease COVID-19 has reached worldwide resonance and a global effort is being undertaken to characterize the molecular features and evolutionary origins of this virus. In this paper, we set out to shed light on the SARS-CoV-2/host receptor recognition, a crucial factor for successful virus infection. Based on the current knowledge of the interactome between SARS-CoV-2 and host cell proteins, we performed Master Regulator Analysis to detect which parts of the human interactome are most affected by the infection. We detected, amongst others, affected apoptotic and mitochondrial mechanisms, and a downregulation of the ACE2 protein receptor, notions that can be used to develop specific therapies against this new virus.https://www.mdpi.com/2077-0383/9/4/982coronavirusbioinformaticsgene network analysisCOVID-19SARS-CoV-2
collection DOAJ
language English
format Article
sources DOAJ
author Pietro H. Guzzi
Daniele Mercatelli
Carmine Ceraolo
Federico M. Giorgi
spellingShingle Pietro H. Guzzi
Daniele Mercatelli
Carmine Ceraolo
Federico M. Giorgi
Master Regulator Analysis of the SARS-CoV-2/Human Interactome
Journal of Clinical Medicine
coronavirus
bioinformatics
gene network analysis
COVID-19
SARS-CoV-2
author_facet Pietro H. Guzzi
Daniele Mercatelli
Carmine Ceraolo
Federico M. Giorgi
author_sort Pietro H. Guzzi
title Master Regulator Analysis of the SARS-CoV-2/Human Interactome
title_short Master Regulator Analysis of the SARS-CoV-2/Human Interactome
title_full Master Regulator Analysis of the SARS-CoV-2/Human Interactome
title_fullStr Master Regulator Analysis of the SARS-CoV-2/Human Interactome
title_full_unstemmed Master Regulator Analysis of the SARS-CoV-2/Human Interactome
title_sort master regulator analysis of the sars-cov-2/human interactome
publisher MDPI AG
series Journal of Clinical Medicine
issn 2077-0383
publishDate 2020-04-01
description The recent epidemic outbreak of a novel human coronavirus called SARS-CoV-2 causing the respiratory tract disease COVID-19 has reached worldwide resonance and a global effort is being undertaken to characterize the molecular features and evolutionary origins of this virus. In this paper, we set out to shed light on the SARS-CoV-2/host receptor recognition, a crucial factor for successful virus infection. Based on the current knowledge of the interactome between SARS-CoV-2 and host cell proteins, we performed Master Regulator Analysis to detect which parts of the human interactome are most affected by the infection. We detected, amongst others, affected apoptotic and mitochondrial mechanisms, and a downregulation of the ACE2 protein receptor, notions that can be used to develop specific therapies against this new virus.
topic coronavirus
bioinformatics
gene network analysis
COVID-19
SARS-CoV-2
url https://www.mdpi.com/2077-0383/9/4/982
work_keys_str_mv AT pietrohguzzi masterregulatoranalysisofthesarscov2humaninteractome
AT danielemercatelli masterregulatoranalysisofthesarscov2humaninteractome
AT carmineceraolo masterregulatoranalysisofthesarscov2humaninteractome
AT federicomgiorgi masterregulatoranalysisofthesarscov2humaninteractome
_version_ 1725021816682971136